<

Recombine Garners $3,300,000 New Funding

  • Feed Type
  • Date
    3/5/2014
  • Company Name
    Recombine
  • Mailing Address
    32 Union Square East New York, NY 10003
  • Company Description
    Recombine provides comprehensive and cost-effective clinical genetic testing. Recombine’s genetic test is designed to deliver clear and actionable genetic information and is based on input from leading healthcare providers.
  • Website
    http://www.recombine.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,300,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    FirstMark Capital
  • Venture Investor
    Undisclosed

Trending on Xconomy